These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 32280036)
1. Transfusion reactions: A retrospective analysis of the Iranian national haemovigilance system (INHS) data. Mardani A; Balali MR Transfus Apher Sci; 2020 Aug; 59(4):102767. PubMed ID: 32280036 [TBL] [Abstract][Full Text] [Related]
2. Review of haemovigilance at the Rabat Regional Blood Transfusion Centre in Morocco (2017-2021). Lemssahli I; Benajiba M; Belmekki A Pan Afr Med J; 2024; 47():60. PubMed ID: 38646139 [TBL] [Abstract][Full Text] [Related]
3. A Retrospective Analysis of Transfusion Reactions at a Tertiary Care Center: An Institutional Hemovigilance Study. Korkmaz E; Korkut S; Akkoyun N J Contin Educ Nurs; 2021 Dec; 52(12):581-588. PubMed ID: 34870535 [TBL] [Abstract][Full Text] [Related]
4. Acute blood transfusion reactions in a tertiary care hospital in Pakistan - an initiative towards haemovigilance. Borhany M; Anwar N; Tariq H; Fatima N; Arshad A; Naseer I; Shamsi T Transfus Med; 2019 Aug; 29(4):275-278. PubMed ID: 29845667 [TBL] [Abstract][Full Text] [Related]
5. Frequency and pattern of noninfectious adverse transfusion reactions at a tertiary care hospital in Korea. Cho J; Choi SJ; Kim S; Alghamdi E; Kim HO Ann Lab Med; 2016 Jan; 36(1):36-41. PubMed ID: 26522757 [TBL] [Abstract][Full Text] [Related]
6. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012. Harvey AR; Basavaraju SV; Chung KW; Kuehnert MJ Transfusion; 2015 Apr; 55(4):709-18. PubMed ID: 25371300 [TBL] [Abstract][Full Text] [Related]
7. Changes in the incidence of transfusion reactions in hematological patients over the past 30 years. Bojanić I; Lukić M; Plenković F; Raos M; Medenjak M; Ćepulić BG Transfusion; 2022 Mar; 62(3):600-611. PubMed ID: 35149994 [TBL] [Abstract][Full Text] [Related]
8. Eight years with haemovigilance in Norway. What have we learnt? Steinsvåg CT; Espinosa A; Flesland Ø Transfus Apher Sci; 2013 Dec; 49(3):548-52. PubMed ID: 24157220 [TBL] [Abstract][Full Text] [Related]
9. Haemovigilance of reactions associated with red blood cell transfusion: comparison across 17 Countries. Rogers MA; Rohde JM; Blumberg N Vox Sang; 2016 Apr; 110(3):266-77. PubMed ID: 26689441 [TBL] [Abstract][Full Text] [Related]
10. Development of the Chinese Haemovigilance Network and reporting of adverse transfusion reactions from 2018 to 2020. Tian X; Kong Y; Wang J; He R; Li L; Liu Z; Vox Sang; 2022 Aug; 117(8):1027-1034. PubMed ID: 35560059 [TBL] [Abstract][Full Text] [Related]
11. Blood transfusion dynamics in Colombia: Unveiling patterns, reactions and survival rates in multitransfused patients. Bermúdez-Forero MI; García-Otálora MA Vox Sang; 2024 Sep; 119(9):963-972. PubMed ID: 38922908 [TBL] [Abstract][Full Text] [Related]
12. Frequency and timing of all-cause deaths in visits involving suspected transfusion reactions, and the significance of cardiopulmonary disturbances. McVey MJ; Cohen R; Arsenault V; Escorcia A; Tasmin F; Pendergrast J; Lieberman L; Lin Y; Callum J; Cserti-Gazdewich C Vox Sang; 2021 Sep; 116(8):898-909. PubMed ID: 33634884 [TBL] [Abstract][Full Text] [Related]
13. Hemovigilance: the experience of transfusion reaction reporting in a Teaching Hospital. Grandi JL; Grell MC; Areco KCN; Barbosa DA Rev Esc Enferm USP; 2018 Jun; 52():e03331. PubMed ID: 29972432 [TBL] [Abstract][Full Text] [Related]
14. A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history. Kato H; Nakayama T; Uruma M; Okuyama Y; Handa M; Tomiyama Y; Shimodaira S; Takamoto S Vox Sang; 2015 Apr; 108(3):243-50. PubMed ID: 25536173 [TBL] [Abstract][Full Text] [Related]
15. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products. Oakley FD; Woods M; Arnold S; Young PP Transfusion; 2015 Mar; 55(3):563-70. PubMed ID: 25145580 [TBL] [Abstract][Full Text] [Related]
16. Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative. Sharma DK; Datta S; Gupta A Indian J Pharmacol; 2015; 47(4):370-4. PubMed ID: 26285707 [TBL] [Abstract][Full Text] [Related]
17. Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data. Saadah NH; van der Bom JG; Wiersum-Osselton JC; Richardson C; Middelburg RA; Politis C; Renaudier P; Robillard P; Schipperus MR Br J Haematol; 2018 Mar; 180(5):727-734. PubMed ID: 29318576 [TBL] [Abstract][Full Text] [Related]
18. The practice of diagnosing and reporting transfusion-associated circulatory overload: a national survey among physicians and haemovigilance officers. Bosboom JJ; Klanderman RB; Peters AL; van de Weerdt EK; Goudswaard EJ; Binnekade JM; Zwaginga JJ; Beckers EAM; Geerts BF; Hollmann MW; Zeerleder SS; van Kraaij M; Vlaar AP Transfus Med; 2018 Oct; 28(5):363-370. PubMed ID: 29058354 [TBL] [Abstract][Full Text] [Related]
19. Determining the true incidence of acute transfusion reactions: Active surveillance at a specialized liver center. Sahu A; Bajpai M Hematol Transfus Cell Ther; 2020; 42(4):326-332. PubMed ID: 31838025 [TBL] [Abstract][Full Text] [Related]
20. Patterns of Adverse Transfusion Reactions in a Tertiary Care Centre of North India: A Step Towards Hemovigilance. Bassi R; Aggarwal S; Bhardwaj K; Thakur KK Indian J Hematol Blood Transfus; 2017 Jun; 33(2):248-253. PubMed ID: 28596659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]